Kenvue Inc (NYSE:KVUE) widens global consumer health reach as Russell 1000 Index reflects broad sector movement.

McDermott+ is pleased to bring you Regs & Eggs, a weekly Regulatory Affairs blog by Jeffrey Davis. November 4, 2025 – Trick ...

Reported late-breaking Phase 2 data at SITC for vilastobart demonstrating a 40% ORR in heavily pretreated patients with MSS mCRC without liver metastases and high plasma tumor mutational burden Presen ...

Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a leading biotechnology company pioneering next-generation ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

MediPharm Labs Corp. ("MediPharm" or the "Company"), a pharmaceutical company specialized in precision-based cannabinoids, has filed its Management Information Circular ("MIC" or the "Circular") and ...

These shares are ending the week in the red. But why? The post Why Rox Resources, Telix, TPG Telecom, and Xero shares are ...

AbbVie ABBV is set to report third-quarter 2025 earnings on Oct. 31, before the opening bell. The Zacks Consensus Estimate for the quarter’s sales and earnings is pegged at $15.59 billion and $1.80 ...

Clients of financial advisors may need to ask for extra information, but advisors can do themselves, and their clients, a ...

Merck & Co., Inc. advances global health innovation as the Russell 1000 Index reflects its broad sector influence.

The best healthcare stocks from Goldman Sachs' list that are also Quant Strong Buys have attractive valuations and forward ...

Sponsored by: Diagnostica Stago, Inc. Unfractionated Heparin (UFH) is a fast-acting anticoagulant used to prevent and treat thromboembolic disorders and requires close laboratory monitoring due to its ...